No Data
PureTech Health Updates on Share Capital and Voting Rights
PureTech Founded Entity Seaport Therapeutics Announces Publication Of Research Demonstrating Increased Lymphatic Transport With Up To 55% Drug Absorption Via Lymphatics With GlyphTM Platform
Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport With up to 55 Percent Drug Absorption via Lymphatics With Glyph Platform
PureTech Scientific Names Nav Arora as New CCO
Top Premarket Gainers
PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}